Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR
302 results:

  • 1. Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses.
    Tapia-Galisteo A; Sánchez-Rodríguez I; Narbona J; Iglesias-Hernández P; Aragón-García S; Jiménez-Reinoso A; Compte M; Khan S; Tsuda T; Chames P; Lacadena J; Álvarez-Vallina L; Sanz L
    Oncoimmunology; 2024; 13(1):2338558. PubMed ID: 38623463
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. B7-H3 Expression in Breast cancer and Brain Metastasis.
    Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy.
    Shebbo S; Binothman N; Darwaish M; Niaz HA; Abdulal RH; Borjac J; Hashem AM; Mahmoud AB
    Front Immunol; 2024; 15():1350208. PubMed ID: 38533510
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy.
    Maia A; Tarannum M; Lérias JR; Piccinelli S; Borrego LM; Maeurer M; Romee R; Castillo-Martin M
    Cells; 2024 Mar; 13(5):. PubMed ID: 38474415
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. IL-15-secreting car natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.
    Van den Eynde A; Gehrcken L; Verhezen T; Lau HW; Hermans C; Lambrechts H; Flieswasser T; Quatannens D; Roex G; Zwaenepoel K; Marcq E; Joye P; Cardenas De La Hoz E; Deben C; Gasparini A; Montay-Gruel P; Le Compte M; Lion E; Lardon F; Van Laere S; Siozopoulou V; Campillo-Davo D; De Waele J; Pauwels P; Jacobs J; Smits E; Van Audenaerde JRM
    J Hematol Oncol; 2024 Feb; 17(1):8. PubMed ID: 38331849
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Novel immunotherapies for breast cancer: Focus on 2023 findings.
    Lan HR; Chen M; Yao SY; Chen JX; Jin KT
    Int Immunopharmacol; 2024 Feb; 128():111549. PubMed ID: 38266449
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. New immunotherapy approaches for colorectal cancer: focusing on car-T cell, BiTE, and oncolytic viruses.
    Kamrani A; Nasiri H; Hassanzadeh A; Ahmadian Heris J; Mohammadinasab R; Sadeghvand S; Sadeghi M; Valedkarimi Z; Hosseinzadeh R; Shomali N; Akbari M
    Cell Commun Signal; 2024 Jan; 22(1):56. PubMed ID: 38243252
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Regulation of the colon-targeted release rate of lactoferrin by constructing hydrophobic ethyl cellulose/pectin composite nanofibrous carrier and its effect on anti-colon cancer activity.
    Wei YS; Feng K; Wu H
    Int J Biol Macromol; 2024 Mar; 261(Pt 1):129466. PubMed ID: 38242414
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The combined detection of hematological indicators is used for the differential diagnosis of colorectal cancer and benign-colorectal lesions.
    Zhang X; Wu YY; Qin YY; Lin FQ
    Cancer Biomark; 2024; 39(3):223-230. PubMed ID: 38217586
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Exploring preventive care practices among unvaccinated individuals in the United States during the COVID-19 pandemic.
    Filipas DK; Labban M; Beatrici E; Stone BV; Qian Z; D Andrea V; Ludwig TA; Reis LO; Cole AP; Trinh QD
    Vaccine; 2024 Jan; 42(3):441-447. PubMed ID: 38184391
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting colorectal cancer cells using AND-gated adaptor Revcar T-cells.
    Soto KEG; Loureiro LR; Bartsch T; Arndt C; Kegler A; Mitwasi N; Drewitz L; Hoffmann L; Saleh HA; Crespo E; Mehnert M; Daglar C; Abken H; Momburg F; Bachmann M; Feldmann A
    Front Immunol; 2023; 14():1302354. PubMed ID: 38169746
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Unraveling the multifaceted role of EpCAM in colorectal cancer: an integrated review of its function and interplay with non-coding RNAs.
    Jiang X; Wang S; Liang Q; Liu Y; Liu L
    Med Oncol; 2023 Dec; 41(1):35. PubMed ID: 38151631
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing.
    Juraske C; Krissmer SM; Teuber ES; Parigiani MA; Strietz J; Wesch D; Kabelitz D; Minguet S; Schamel WW
    J Leukoc Biol; 2024 Jan; 115(2):293-305. PubMed ID: 38149982
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cumulative Absolute Risk of Subsequent colorectal cancer After Abdominopelvic Radiotherapy Among Childhood cancer Survivors: A PancareSurFup Study.
    Heymer EJ; Jóźwiak K; Kremer LC; Winter DL; de Vathaire F; Sunguc C; Sugden E; Kok JL; van der Pal HJH; Hjorth L; Jakab Z; Maule MM; Haupt R; Bagnasco F; Terenziani M; Diallo I; Gunnes MW; Sommer G; Zadravec Zaletel L; Kuehni CE; Winther JF; Lähteenmäki PM; Gudmundsdottir T; Allodji RS; Skinner R; Ronckers CM; Hawkins MM; Reulen RC; Teepen JC
    J Clin Oncol; 2024 Jan; 42(3):336-347. PubMed ID: 37972325
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Implications of single-cell immune landscape of tumor microenvironment for the colorectal cancer diagnostics and therapy.
    Alzamami A
    Med Oncol; 2023 Nov; 40(12):352. PubMed ID: 37950801
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Translational research of new developments in targeted therapy of colorectal cancer.
    Yang L; Atakhanova N; Arellano MTC; Mohamed MY; Hani T; Fahdil AA; Castillo-Acobo RY; Juyal A; Hussein AK; Amin AH; Pecho RDC; Akhavan-Sigari R
    Pathol Res Pract; 2023 Dec; 252():154888. PubMed ID: 37948996
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. CLMP is a tumor suppressor that determines all-trans retinoic acid response in colorectal cancer.
    Wu Z; Zhang X; An Y; Ma K; Xue R; Ye G; Du J; Chen Z; Zhu Z; Shi G; Ding X; Wan M; Jiang B; Zhang P; Liu J; Bu P
    Dev Cell; 2023 Dec; 58(23):2684-2699.e6. PubMed ID: 37944525
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. H1Innovative approaches to combat anti-cancer drug resistance: Targeting lncRNA and autophagy.
    Zhong C; Xie Z; Duan S
    Clin Transl Med; 2023 Oct; 13(10):e1445. PubMed ID: 37837401
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Probiotic-guided car-T cells for solid tumor targeting.
    Vincent RL; Gurbatri CR; Li F; Vardoshvili A; Coker C; Im J; Ballister ER; Rouanne M; Savage T; de Los Santos-Alexis K; Redenti A; Brockmann L; Komaranchath M; Arpaia N; Danino T
    Science; 2023 Oct; 382(6667):211-218. PubMed ID: 37824640
    [TBL] [Abstract] [Full Text] [Related]  


    of 16.